Particle.news
Download on the App Store
47 ARTICLES
·
yesterday

RFK Jr.’s Appointed Vaccine Panel Bars Thimerosal Flu Shots, Endorses New RSV Antibody

The panel’s decisions now await CDC review with concerns that eliminating multi-dose vials could hamper vaccination efforts in underserved areas.

Lyn Redwood, a nurse practitioner who once led anti-vaccine organizations, presented on thimerosal in flu vaccines Thursday at a meeting of the CDC's Advisory Committee on Immunization Practices.
FILE - A nurse prepares a flu shot from a vaccine vial at the Salvation Army in Atlanta, Feb. 7, 2018. (AP Photo/David Goldman, File)
Image

Overview

  • HHS Secretary RFK Jr. dissolved the 17-member ACIP on June 9 and installed a seven-member panel including individuals with anti-vaccine ties.
  • The reshaped ACIP voted 5-1 to recommend eliminating thimerosal-containing multi-dose flu vaccines for all demographics despite decades of studies confirming its safety.
  • The committee approved clesrovimab, Merck’s new monoclonal antibody for RSV in infants, by a 5-2 margin to supplement existing prevention tools.
  • A CDC-prepared document rebutting anti-thimerosal claims was removed from public view and a vacant CDC director post leaves final approval in limbo.
  • Experts caution that limiting access to multi-dose vials could drive up costs and impede flu vaccination efforts in underserved and low-income regions.